0001593968-19-001649.txt : 20190723
0001593968-19-001649.hdr.sgml : 20190723
20190723161927
ACCESSION NUMBER: 0001593968-19-001649
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190722
FILED AS OF DATE: 20190723
DATE AS OF CHANGE: 20190723
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: El-Hibri Fuad
CENTRAL INDEX KEY: 0001380185
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 19968004
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD, SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2019-07-22
0001671584
Aptevo Therapeutics Inc.
APVO
0001380185
El-Hibri Fuad
2401 4TH AVENUE
SUITE 1050
SEATTLE
WA
98121
true
false
true
false
Board of Directors
Common Stock
2019-07-22
4
P
false
30000
0.8867
A
959521
D
The purchase price of $0.8867 is reflective of the weighted average purchase price. The prices for the transactions reported on this line range from $0.88 to $0.90. Mr. El-Hibri undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
/s/ El-Hibri, Faud
2019-07-23